Construction of a Dataset for All Expressed Transcripts for Alzheimer’s Disease Research
Open Access
- 25 November 2024
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 14 (12) , 1180
Abstract
Accurate identification and functional annotation of splicing isoforms and non-coding RNAs (lncRNAs), alongside full-length protein-encoding transcripts, are critical for understanding gene (mis)regulation and metabolic reprogramming in Alzheimer’s disease (AD). This study aims to provide a comprehensive and accurate transcriptome resource to improve existing AD transcript databases. Background/Objectives: Gene mis-regulation and metabolic reprogramming play a key role in AD, yet existing transcript databases lack accurate and comprehensive identification of splicing isoforms and lncRNAs. This study aims to generate a refined transcriptome dataset, expanding the understanding of AD onset and progression. Methods: Publicly available RNA-seq data from pre-AD and AD tissues were utilized. Advanced bioinformatics tools were applied to assemble and annotate full-length transcripts, including splicing isoforms and lncRNAs, with an emphasis on correcting errors and enhancing annotation accuracy. Results: A significantly improved transcriptome dataset was generated, which includes detailed annotations of splicing isoforms and lncRNAs. This dataset expands the scope of existing AD transcript databases and provides new insights into the molecular mechanisms underlying AD. The findings demonstrate that the refined dataset captures more relevant details about AD progression compared to publicly available data. Conclusions: The newly developed transcriptome resource and the associated analysis tools offer a valuable contribution to AD research, providing deeper insights into the disease’s molecular mechanisms. This work supports future research into gene regulation and metabolic reprogramming in AD and serves as a foundation for exploring novel therapeutic targets.Keywords
Funding Information
- National Natural Science Foundation of China (T2350010, 2022KSYS007, W2431059)
- Key University Laboratory of Metabolism and Health of Guangdong, Southern University of Science and Technology, Shenzhen 518055, China (T2350010, 2022KSYS007, W2431059)
- National Natural Science Fund of China Research Fund for International Scientists (T2350010, 2022KSYS007, W2431059)
This publication has 66 references indexed in Scilit:
- Understanding Alzheimer’s disease at the chemistry level2024
- The mTOR–lysosome axis at the centre of ageingFEBS Open Bio, 2021
- Systematic analysis to identify transcriptome-wide dysregulation of Alzheimer’s disease in genes and isoformsHuman Genetics, 2020
- Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional 31P MR spectroscopic imaging studyNeuroImage: Clinical, 2018
- Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer’s Disease Not Evident in Mouse ModelsCell Reports, 2018
- mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagyNeurobiology of Disease, 2015
- Amyloid-β and TauJAMA Neurology, 2014
- Evolution and Functions of Long Noncoding RNAsCell, 2009
- Computational Approaches and Tools Used in Identification of Dispersed Repetitive DNA SequencesTropical Plant Biology, 2008
- Acid-sensing ion channels (ASICs) as pharmacological targets for neurodegenerative diseasesCurrent Opinion in Pharmacology, 2008